9:22 AM
Leo Group India
| ||
| Mylan Pharma launches generic anti-stroke tablets The Hindu Nasdaq listed-Mylan Inc on Friday announced that its subsidiary Mylan Pharmaceuticals Inc has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clopidogrel tablets. See all stories on this topic » | ||
| Pharmaceutical industry eludes Odisha Times of India BHUBANESWAR: Pharmaceutical professionals in Odisha on Thursday rued that despite the state producing over 2000 pharmaceutical professionals every year, there is hardly any pharma industry in the state. SR Mishra, director of Jeypore College of ... See all stories on this topic » | ||
| DRL, Sun Pharma, Aurobindo and Torrent Pharma get US FDA nod for generic ... pharmabiz.com Indian pharma majors viz Dr Reddy's Laboratories, Sun Pharmaceuticals, Aurobindo Pharma and Torrent Pharma have benefited from approval of generic versions of the blood thinning drug Plavix (clopidogrel bisulfate) by US FDA along with other ... See all stories on this topic » | ||
| Sagent Pharmaceuticals Announces Launch of Atracurium Besylate Injection, USP MarketWatch (press release) SCHAUMBURG, Ill., May 18, 2012 (GlobeNewswire via COMTEX) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced the launch of Atracurium Besylate Injection, USP, the generic form of the neuromuscular blocker Tracrium(R), in 50 mg per 5 mL ... See all stories on this topic » | ||
| Dr Reddy's, Sun Pharma and Aurobindo get US nod for cardiac drug Moneylife Personal Finance site and magazine Hyderabad: Pharmaceutical companies, Dr Reddy's Laboratories, Sun Pharma and Aurobindo Pharma on Friday said they have received US health regulator's approval to sell generic Plavix, used in treating heart diseases, in the American market, reports PTI. See all stories on this topic » | ||
| Watson Confirms Lo Loestrin® Fe Patent Challenge MarketWatch (press release) PARSIPPANY, NJ, May 18, 2012 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration ... See all stories on this topic » | ||
| Pharmaceutical Industry Labor-Management Association (PILMA) Statement on ... MarketWatch (press release) WASHINGTON, May 17, 2012 /PRNewswire via COMTEX/ -- The Pharmaceutical Industry Labor-Management Association (PILMA) today called on members of the Senate to support the swift and streamlined process for the reauthorization of the Prescription Drug ... See all stories on this topic » | ||
| Elevation Pharma reports positive phase II b results for EP-101 in COPD patients pharmabiz.com Elevation Pharmaceuticals Inc., a pharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, has reported positive results from a phase II b study of EP-101 in patients with chronic obstructive ... See all stories on this topic » | ||
| FII inflows: Kahin khushi, kahin gham for Gujarat cos Daily News & Analysis FII holdings in Torrent Group's Torrent Pharmaceuticals, a company promoted by the brothers Sudhir & Samir Mehta, benefited with 1.26% gain. Torrent Power, on the other hand, experienced marginal improvement. The last fiscal was a damper as many ... See all stories on this topic » | ||
|
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment